Cancer care requires a personalized, team-based approach. Collaboration among researchers, providers and patients is crucial to advancing treatment.
Where I see patients (2)
My reviews
Selected research
-
Complete response of somatic POLE-ultramutated recurrent undifferentiated uterine sarcoma to pembrolizumab and concurrent radiotherapy.
Gynecologic oncology reports
-
Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage Activation.
JCO oncology advances
-
The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma.
Cancers
4.9